Caricamento...
B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy
BACKGROUND: B-cell depletion can improve a variety of chronic inflammatory diseases, but does not appear beneficial for patients with Crohn’s disease. OBJECTIVE: To elucidate the involvement of B cells in Crohn’s disease, we here performed an ‘in depth’ analysis of intestinal and blood B-cells in th...
Salvato in:
Pubblicato in: | PLoS One |
---|---|
Autori principali: | , , , , , , , , , , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Public Library of Science
2016
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965034/ https://ncbi.nlm.nih.gov/pubmed/27468085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0160103 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|